thiazolyl blue has been researched along with Diabetic Neuropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasi, Z; Khaksari, M; Nazarnezhad, S; Rahmati, M; Salehi, M; Shayannia, A | 1 |
1 other study(ies) available for thiazolyl blue and Diabetic Neuropathies
| Article | Year |
|---|---|
Nesfatin-1 protects PC12 cells against high glucose-induced cytotoxicity via inhibiting oxidative stress, autophagy and apoptosis.
Topics: Animals; Apoptosis; Autophagy; Cell Survival; Diabetic Neuropathies; Glucose; Membrane Potential, Mitochondrial; Necrosis; Neuroprotective Agents; Nucleobindins; Oxidative Stress; PC12 Cells; Rats; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2019 |